Related content

XELIRI compared with FOLFIRI as a secondline treatment in patients with metastatic colorectal cancer

By                  

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1864-1872

Spandidos Publications

Access to resources Recommend Favorite

Oral multikinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer

By Cremolini Chiara   Schirripa Marta   Loupakis Fotios   Falcone Alfredo  

Colorectal Cancer, Vol. 2, Iss. 5, 2013-10 ,pp. : 411-417

Future Medicine

Access to resources Recommend Favorite

Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer

By Meadows Sherry   Mulkerin Daniel   Berlin Jordan   Bailey Howard   Kolesar Jill   Warren Deb   Thomas James  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 2-3, 2002-12 ,pp. : 125-128

Humana Press, Inc

Access to resources Recommend Favorite

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite

Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients

By Saito Seiya   Hayashi Naoko   Sato Nobutaka   Iwatsuki Masaaki   Baba Yoshifumi   Sakamoto Yasuo   Miyamoto Yuji   Watanabe Masayuki   Yoshida Minoru   Sakai Kenji   Katsumori Takashi   Katahuchi Shigeru   Shigaki Nobuyuki   Yamada Kazutaka   Kimura Masami   Tanigawa Tomio   Takano Sadamu   Kuramoto Masafumi   Baba Hideo  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 689-695

Springer Publishing Company

Access to resources Recommend Favorite